EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression

Amal M El-Naggar iD, Yuqin Li, Busra Turgu, Yuchen Ding, Longyijie Wei, Shary Yuting Chen, Genny Trigo-Gonzalez, Forouh Kalantari, Rodrigo Vallejos iD, Branden Lynch iD, Janine Senz, Amy Lum und 16 weitere

The Journal of Pathology · 2025-07 · 266 (3) · 352-367

DOI: 10.1002/path.6433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 15.05.2025. Verfasst von Amal M El-Naggar und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Cystathionine gamma-Lyase, Hypoxia-Inducible Factor 1, alpha Subunit, Ovarian Neoplasms, Adenocarcinoma, Clear Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR) Foundation, Terry Fox Research Institute, Dr. Chew Wei Professorship-in Gynaecologic Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell ovarian cancer (CCOC) is the second most common ovarian cancer subtype, accounting for 5%–11% of ovarian cancers in North America. Late‐stage CCOC is associated with a worse prognosis compared to other ovarian cancer histotypes, a challenge that has seen limited progress in recent decades. CCOC typically originates within the toxic microenvironment of endometriotic ovarian cysts and is characterized by its intrinsic chemoresistance, a strong hypoxic signature, and abundant expression of cystathionine gamma‐lyase (CTH). CTH is a key enzyme in the transsulfuration pathway and serves as a marker of ciliated cells derived from the Müllerian tract. CTH plays a pivotal role in de novo cysteine synthesis, which is essential for glutathione (GSH) production and redox homeostasis. Using an array of molecular tools and cancer models, including in vivo studies, we demonstrated that CTH expression was induced under various stress conditions, such as exposure to endometriotic cyst content and hypoxia. This induction enables cell survival and creates a differentiation state manifested by CCOC that potentiates tumor progression and metastasis. In addition to regulating redox homeostasis, CTH enhances hypoxia inducible factor 1‐alpha (HIF1α) expression, independently of hydrogen sulfide (H 2 S) production. Re‐expression of HIF1α in CTH KO cells fully restored metastatic capacity in in vivo models. Co‐expression of CTH and HIF1α proteins was also observed in human CCOC samples. Importantly, targeting CTH in CCOC significantly reduced its metastatic potential in in vivo models and enhanced sensitivity to chemotherapy. These findings underscore that CTH is both a defining feature of CCOC and a promising therapeutic target, not only for CCOC patients but also for those with other CTH‐expressing cancers. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystathionine gamma-LyaseHypoxia-Inducible Factor 1, alpha SubunitOvarian NeoplasmsAdenocarcinoma, Clear CellFemaleHumansAnimalsDisease ProgressionGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

CCOCCTHH2SHIF1αchemoresistantendometriosishypoxiametastatic progressionredox regulation

Substanzen

Cystathionine gamma-LyaseHypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, human

Autor:innen und Institutionen

  • Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Department of Pathology, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt.
  • Molecular and Advanced Pathology Core (MAPCore), University of British Columbia, Vancouver, BC, Canada.
  • BC Centre for Pelvic Pain and Endometriosis, BC Women's Hospital, Vancouver, BC, Canada.
  • Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada.

ORCID-Profile: Amal M El-Naggar, Rodrigo Vallejos, Branden Lynch, Gian Luca Negri, Yemin Wang, David G Huntsman

Förderung

  • Canadian Institutes of Health Research (CIHR) Foundation
  • Terry Fox Research Institute
  • Dr. Chew Wei Professorship-in Gynaecologic Oncology
  • Canada Research Chairs
  • Ovarian Cancer Canada :
  • Cancer Research Society
  • Gynaecologic Cancer Initiative (GCI)/OVCARE Carraresi
  • Canada Cancer Society

Zitieren

APA

El-Naggar, A. M., Li, Y., Turgu, B., Ding, Y., Wei, L., Chen, S. Y., Trigo-Gonzalez, G., Kalantari, F., Vallejos, R., Lynch, B., Senz, J., Lum, A., Douglas, J. M., Salamanca, C., Thornton, S., Qin, Y., Parmar, K., Spencer, S. E., Leung, S., …, & Huntsman, D. G. (2025). Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression. The Journal of Pathology, 266(3), 352-367. https://doi.org/10.1002/path.6433

Vancouver

El-Naggar AM, Li Y, Turgu B, Ding Y, Wei L, Chen SY, et al. Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression. The Journal of Pathology. 2025;266(3):352-367. doi:10.1002/path.6433

BibTeX
@article{ElNaggar2025,
  author = {El-Naggar, Amal M and Li, Yuqin and Turgu, Busra and Ding, Yuchen and Wei, Longyijie and Chen, Shary Yuting and Trigo-Gonzalez, Genny and Kalantari, Forouh and Vallejos, Rodrigo and Lynch, Branden and Senz, Janine and Lum, Amy and Douglas, J Maxwell and Salamanca, Clara and Thornton, Shelby and Qin, Yimei and Parmar, Kiran and Spencer, Sandra E and Leung, Samuel and Woo, Michelle M M and Yong, Paul J and Zhang, Hai-Feng and Hughes, Christopher S and Negri, Gian Luca and Wang, Yemin and Morin, Gregg B and Sorensen, Poul H and Huntsman, David G},
  title = {Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression},
  journal = {The Journal of Pathology},
  year = {2025},
  volume = {266},
  number = {3},
  pages = {352--367},
  doi = {10.1002/path.6433}
}
Kostenlos starten →